DCGI nod to Biological E Corbevax as heterologous COVID booster Ruchika Sharma5 Jun 2022 12:00 PM ISTBE's CORBEVAX is the first such vaccine in India to be approved as a heterologous COVID-19 booster.
Biogen, Samsung Bioepis launch USFDA approved BYOOVIZ in US Ruchika Sharma5 Jun 2022 9:00 AM ISTBYOOVIZ is the first biosimilar launch in the U.S. under the Biogen and Samsung Bioepis' partnership.
Pfizer appoints Annaliesa Anderson as Senior Vice President Ruchika Sharma4 Jun 2022 4:52 PM ISTNew York: Pfizer Inc. has announced that Annaliesa Anderson, Ph.D., has been appointed Senior Vice President and Head of the Company's Vaccine...
Thyrocare inaugurates Regional Processing Lab in Ahmedabad Ruchika Sharma4 Jun 2022 3:51 PM ISTThe new Regional Processing Lab at Ahmedabad has a capacity to process 3000 samples in a day.
USFDA flags heart inflammation risk after taking Novavax COVID vaccine Ruchika Sharma4 Jun 2022 3:09 PM ISTThe FDA said it had requested Novavax to flag myocarditis and another kind of heart inflammation as an "important identified risk" in its materials.
Boehringer Ingelheim, A*STAR ink pact for targeted cancer therapies Ruchika Sharma4 Jun 2022 10:00 AM ISTA*STAR may receive payments totalling 100 million EUR in upfront and success-based development and commercialization milestones.
Walvax Biotechnology COVID booster stronger against Omicron than Sinovac shot, shows trial data Ruchika Sharma4 Jun 2022 10:00 AM ISTBeijing: A COVID-19 vaccine candidate from China's Walvax Biotechnology using mRNA technology triggered a stronger antibody response against the...
Researchers identify increase in serious neurological disorder cases following AstraZeneca vaccine Ruchika Sharma3 Jun 2022 3:23 PM ISTGuillain-Barre syndrome (GBS) is a rare but serious autoimmune condition that attacks the peripheral nervous system, typically resulting in numbness,...
Study says Pfizer COVID drug Paxlovid reduces COVID risk in seniors regardless of vaccine status Ruchika Sharma3 Jun 2022 1:17 PM ISTPfizer's clinical trial tested Paxlovid in unvaccinated people who had risk factors for serious disease and found that the two-drug treatment cut the...
Sanofi to transfer 100 percent rights of Libtayo to Regeneron Ruchika Sharma3 Jun 2022 12:34 PM ISTUpon closing of the transaction, Regeneron will make an upfront payment of $900 million to Sanofi, which will be entitled to receive an 11% royalty on...
Pfizer-BioNTech seeks USFDA authorisation for COVID vaccine for kids under 5 years Ruchika Sharma3 Jun 2022 11:30 AM ISTNo COVID-19 shot is yet approved for children in that age group in most parts of the world.
Cipla adds capacity of captive renewable energy power plant in Maharashtra, Karnataka Ruchika Sharma3 Jun 2022 10:00 AM ISTThe project will support the Company's green energy requirements for its manufacturing units at Kurkumbh & Patalganga and R&D centre at Vikhroli in...
